JPRN-UMIN000030429已完成未知
Prediction of trastuzumab-induced cardiotoxicity using transthoracic echocardiography and cardiac biomarkers in patients with gastric cancer - Prediction of trastuzumab-induced cardiotoxicity using transthoracic echocardiography and cardiac biomarkers in patients with gastric cancer
Cancer Institute Hospital0 个研究点目标入组 48 人开始时间: 2017年12月16日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 48
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •The investigator's consider unsuitable for registration Suitable echocardiographic data can not be obtained for diagnostic imaging Patients can not have clinical examinations due to bad general condition Patients can not visit the hospital periodically
研究者
相似试验
招募中
不适用
Predictors of Trastuzumab-induced Cardiotoxicity in Breast Cancer PatientsBreast cancer patientTrastuzumabCardiotoxicityBreast cancerTCTR20210209001Faculty of medicine, Chiang Mai University250
招募中
不适用
Can an MRI scan show early signs of medication-related changes to the heart in patients with breast cancer treated with trastuzumab?Trastuzumab-associated cardiomyopathyInjury, Occupational Diseases, PoisoningISRCTN83167415Working Group Cardiac MRI @ Charité University Medicine Berlin & HELIOS Hospital Berlin-Buch30
终止
2 期
Early Detection of Cardiac Toxicity of Trastuzumab (Herceptin ®) in Patients Treated for Breast Carcinoma: Value of Magnetic Resonance ImagingCancer, BreastLV DysfunctionNCT01436604Centre Francois Baclesse19
进行中（未招募）
不适用
Efficacy and toxicity of Trastuzumab at the maintaining dose of 1 mg/kg/week versus the standard dose of 2 mg/kg/week in combination with chemotherapy in metastatic breast cancer patients. A phase III multicenter study. - Dose optimization of TrastuzumabEUCTR2007-006060-29-ITIST - ISTITUTO NAZIONALE PER LA RICERCA SUL CANCRO
Unknown
不适用
Risk Assessment Model of Trastuzumab-related Cardiotoxicity in Breast Cancer PatientsCardiac ToxicityAntitumor DrugsBreast CancerNCT04962425Peking University Third Hospital240